One Ascent Wealth Management LLC Cellectis S.A. Transaction History

One Ascent Wealth Management LLC

  • $263 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$11.94 - $16.09 $314,941 - $424,405
-26,377 Closed
0 $0
Q1 2021

Apr 27, 2021
BUY
$18.19 - $33.25 $50,913 - $93,066
2,799 Added 11.87%
26,377 $533,000
Q4 2020

Feb 08, 2021
BUY
$15.87 - $31.64 $374,182 - $746,007
23,578 New
23,578 $638,000

Others Institutions Holding CLLS

# of Institutions
30
Shares Held
10.8M
Call Options Held
5.9K
Put Options Held
1.4K
View Full List

About Cellectis S.A.

CLLS Quotes by TradingView
  • Ticker CLLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,510,800
  • Market Cap $71M
  • Description
  • Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...
More about CLLS
Track This Portfolio

Track One Ascent Wealth Management LLC Portfolio

Follow One Ascent Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on One Ascent Wealth Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email